Technology & Science
Nov. 25, 2010
Biotech Companies Fall Short in IPOs
When San Diego-based Zogenix Inc. dropped its initial public offering on the market Monday, the stock price fell far from earlier expectations.
Daily Journal Staff Writer
SAN DIEGO - When Zogenix Inc. dropped its initial public offering on the market Monday, the stock price fell far from earlier expectations.
The San Diego-based pharmaceutical company specializing in treatments for central nervous system disorders and pain sold 14 million shares at $4 each, raising $56 million - $40.6 million less than the company said it expected to raise in a Nov. 4 filing with the ...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In